Jeffrey A Rona
CIK 1311404 · View on SEC EDGAR ↗
First SEC filing: Dec. 21, 2020 · Latest: Dec. 21, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | OVID | S | 8,541 | $1.45 | $12,384 | 88,188 Direct | -8.83% | Disposed | 99.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | OVID | Employee Stock Option (Right to Buy) | Common Stock (408,750) | $1.65 | Feb. 25, 2036 | 408,750 | Acquired |
| Feb. 22, 2024 | OVID | Stock Option (Right to Buy) | Common Stock (168,750) | $3.68 | Feb. 21, 2034 | 168,750 | Acquired |
| Feb. 23, 2023 | OVID | Stock Option (Right to Buy) | Common Stock (175,000) | $2.50 | Feb. 22, 2033 | 175,000 | Acquired |
| April 8, 2022 | OVID | Stock Option (Right to Buy) | Common Stock (10,000) | $3.22 | April 7, 2032 | 10,000 | Acquired |
| April 8, 2022 | OVID | Stock Option (Right to Buy) | Common Stock (194,399) | $3.22 | April 7, 2032 | 194,399 | Acquired |
| Feb. 3, 2022 | OVID | Stock Option (Right to Buy) | Common Stock (218,750) | $2.72 | Feb. 2, 2032 | 218,750 | Acquired |
| June 2, 2021 | OVID | Stock Option (Right to Buy) | Common Stock (100,000) | $4.42 | June 1, 2031 | 100,000 | Acquired |
| Dec. 17, 2020 | OVID | Stock Option (Right to Buy) | Common Stock (175,000) | $2.82 | Dec. 16, 2030 | 175,000 | Acquired |
| Oct. 11, 2020 | OVID | Stock Option (Right to Buy) | Common Stock (20,000) | $5.65 | Oct. 10, 2030 | 20,000 | Acquired |
| Sept. 30, 2020 | OVID | Stock Option (Right to Buy) | Common Stock (325,000) | $5.74 | Sept. 29, 2030 | 325,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $506,892 | — | $24,806 | — | $305,000 | — | $14,000 | $969,164 |
| 2024 | $492,128 | — | $103,500 | — | $206,300 | — | $13,800 | $1,518,796 |
| 2023 | $492,128 | — | — | — | $255,907 | — | $13,200 | $1,083,970 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.